Bulletin
Investor Alert

AnaptysBio Inc.

NAS: ANAB

GO
/marketstate/country/us

After Hours

/zigman2/quotes/205822596/composite

$

16.08

Change

+0.0017 +0.01%

Volume

Volume 372,054

Sep 18, 2020, 4:29 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205822596/composite

Previous close

$ 15.81

$ 16.08

Change

+0.27 +1.71%

Day low

Day high

$15.61

$16.18

Open
Open: 15.96

52 week low

52 week high

$10.00

$42.30

Open

Market cap

$439.04M

Average volume

212,561

P/E ratio

N/A

Rev. per Employee

$64,103

EPS

-2.99

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/anab

MarketWatch News on ANAB

  1. AnaptysBio downgraded to hold from buy at SunTrust RH

    9:10 a.m. Nov. 11, 2019

    - Tomi Kilgore

  2. AnaptysBio stock price target cut to $15 from $93 at SunTrust RH

    9:11 a.m. Nov. 11, 2019

    - Tomi Kilgore

  3. AnaptysBio downgraded to sector perform from outperform at RBC Capital

    8:38 a.m. April 4, 2018

    - Tomi Kilgore

  4. AnaptysBio started at buy with $115 stock price target at SunTrust RH

    8:44 a.m. Nov. 15, 2017

    - Tomi Kilgore

  5. Charting the Market

    1:27 a.m. Oct. 14, 2017

    - Barron's Online

  6. Consumer Confidence Seen to Be Waning

    4:33 a.m. July 22, 2017

    - Barron's Online

  7. The IPO market is back, baby!

    7:05 a.m. March 31, 2017

    - Caitlin Huston

  8. AnaptysBio started at outperform with $28 stock price target at Wedbush Securities

    8:30 a.m. Feb. 21, 2017

    - Tomi Kilgore

  9. AnaptysBio started at buy with $30 stock price target at Stifel Nicolaus

    8:29 a.m. Feb. 21, 2017

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/anab

Other News on ANAB

  1. 10-Q: ANAPTYSBIO, INC

    8:19 a.m. Aug. 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  2. AnaptysBio expands executive leadership team

    10:04 a.m. July 15, 2020

    - Seeking Alpha

  3. AnaptysBio names new executives

    10:04 a.m. July 15, 2020

    - Seeking Alpha

  4. IPO Update: Pandion Therapeutics Seeks $94 Million IPO

    2:48 p.m. July 14, 2020

    - Seeking Alpha

  5. Will AnaptysBio Continue to Surge Higher?

    11:10 a.m. May 11, 2020

    - Zacks.com

  6. Is AnaptysBio (ANAB) Stock a Solid Choice Right Now?

    10:48 a.m. May 11, 2020

    - Zacks.com

  7. 10-Q: ANAPTYSBIO, INC

    4:34 p.m. May 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  8. Lyra Therapeutics Aims For U.S. IPO In Choppy Market

    4:39 p.m. March 9, 2020

    - Seeking Alpha

  9. 10-K: ANAPTYSBIO, INC

    10:00 a.m. March 2, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  10. What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock

    1:00 p.m. Jan. 6, 2020

    - Zacks.com

  11. Loading more headlines...
/news/pressrelease/company/us/anab

Press Releases on ANAB

  1. Shuman Glenn & Stecker Investigates AnaptysBio, Inc.

    9:30 a.m. Aug. 24, 2020

    - BusinessWire - BZX

  2. AnaptysBio Appoints Dr. Paul F. Lizzul As Chief Medical Officer

    8:30 a.m. July 31, 2020

    - GlobeNewswire

  3. AnaptysBio Appoints Dr. Paul F. Lizzul As Chief Medical Officer

    8:30 a.m. July 31, 2020

    - GlobeNewswire

  4. AnaptysBio Expands Executive Leadership Team

    8:30 a.m. July 15, 2020

    - GlobeNewswire

  5. AnaptysBio Expands Executive Leadership Team

    8:30 a.m. July 15, 2020

    - GlobeNewswire

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.